| [1] |
Bagley RG. 肿瘤微环境[M].覃文新,樊嘉,译. 杭州:浙江大学出版社,2013:51-78.
|
| [2] |
张金忠,戈伟,张园如,等.CT/CT 图像融合用于非小细胞肺癌放射治疗对V20 及放射性肺炎影响的临床研究[J]. 临床肿瘤学杂志,2011,16(2):154-157.
|
| [3] |
Korhonen K, Parkkila AK, Helen P, et al. Carbonic anhydrases in meningiomas: association of endothelial carbonic anhydrase II with aggressive tumor features[J]. J Neurosurg,2009,111(3):472-477.
|
| [4] |
Pastorekova S, Ratcliffe PJ, Pastorek J. Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia[J]. BJU Int,2008,101 Suppl 4:8-15.
|
| [5] |
Svastova E, Witarski W, Csaderova L, et al. Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain[J].J Biol Chem,2012,287(5):3392-3402.
|
| [6] |
Swietach P, Wigfield S, Cobden P, et al. Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths [J]. J Biol Chem,2008,283(29):20473-20483.
|
| [7] |
Orlowski A, De Giusti VC, Morgan PE, et al. Binding of carbonic anhydrase IX to extracellular loop 4 of the NBCe1 Na+/HCO3-cotransporter enhances NBCe1-mediated HCO3-influx in the rat heart[J]. Am J Physiol Cell Physiol,2012,303(1): C69-C80.
|
| [8] |
Zatoviˇcová M, Pastoreková S.Modulation of cell surface density of carbonic anhydrase IX by shedding of the ectodomain and endocytosis[J].Acta Virol,2013,57(2):257-264.
|
| [9] |
Barathova M, Takacova M, Holotnakova T, et al. Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype[J].Br J Cancer,2008,98(1):129-136.
|
| [10] |
Ditte P, Dequiedt F, Svastova E, et al. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors[J]. Cancer Res,2011,71 (24):7558-7567.
|
| [11] |
Zatovicova M, Jelenska L, Hulikova A, et al. Carbonic anhydrase IX as ananticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain[J]. Curr Pharm Des,2010,16(29):3255-3263.
|
| [12] |
Chen JL, Lucas JE, Schroeder T, et al. The genomic analysis of lactic acidosis and acidosis response in human cancers[J].PLoS Genet,2008,4(12):e1000293.
|
| [13] |
Li MP, Ren LF, Cai HG, et al. Significance of carbonic anhydrase IX protein expression in molecular subtyping of breast cancers[J]. Zhonghua Bing Li Xue Za Zhi,2013,42(3):182-185.
|
| [14] |
Neumeister VM, Sullivan CA, Lindner R, et al. Hypoxiainduced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer[J]. Breast Cancer Res Treat,2012,136(1):67-75
|
| [15] |
Li Y, Wang H, Oosterwijk E, et al. Antibody-specific detection of CAⅨin breast and prostate cancers[J]. Biochem Biophys Res Commun,2009,386(3):488-492.
|
| [16] |
Brennan DJ, Jirstrom K, Kronblad A, et al. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance[J]. Clin Cancer Res, 2006,12(21):6421-6431.
|
| [17] |
Hussain SA, Ganesan R, Reynolds G, et al. Hypoxiaregulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer[J]. Br J Cancer,2007,96(1):104 -109
|
| [18] |
Kaya AO, Gunel N, Benekli M, et al. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients [J]. J BUON,2012,17(4):663-668.
|
| [19] |
Trastour C, Benizri E, Ettore F, et al. HIF-1a and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome[J].Int J Cancer,2007,120(1):1451-1458.
|
| [20] |
Schütze D, Milde-Langosch K, Witzel I,et al. Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer[J]. J Cancer Res Clin Oncol,2013,139(5):747-754.
|
| [21] |
Tafreshi NK, Bui MM, Bishop K, et al. Noninvasive Detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes[J].Clin Cancer Res,2012,18(1):207-219.
|
| [22] |
Müller V, Riethdorf S, Rack B, et al. Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer[J]. Breast Cancer Res,2011,13(4):R71.
|
| [23] |
Vermeulen JF, van Brussel AS, van der Groep P, et al.Immunophenotyping invasive breast cancer: paving the road for molecular imaging[J].BMC Cancer,2012,12:240.
|
| [24] |
Li G, Passebosc-Faure K, Feng G, et al. MN/CA9: a potential gene marker for detection of malignant cells in effusions[J].Biomarkers,2007,12(2):214-220.
|
| [25] |
Betof AS,Rabbani ZN,Hardee ME,et al. Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification[J].Br J Cancer,2012,106(5):916-922.
|
| [26] |
Liu GY, Shen KW, Shao ZM, et al. Hypoxia induces downregulation of estrogen receptor alpha in human breast cancer[J].Zhonghua Zhong Liu Za Zhi,2004,26(11):664-668.
|
| [27] |
Voss MJ, Möller MF, Powe DG, et al. Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism [J]. BMC Cancer,2011,11:158.
|
| [28] |
Loges S, Mazzone M, Hohensinner P, et al. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited [J].Cancer Cell,2009,15(3):167-170.
|
| [29] |
杨后圃,王殊. 转化医学助力21 世纪的乳腺癌研究[J/CD].中华乳腺病杂志:电子版,2014,8(1):9-12.
|
| [30] |
Mulders P, Bleumer I, Debruyne F, et al. Specific monoclonal antibody-based immunotherapy by targeting the RCC-associated antigen carbonic anhydrase-IX(G250/MN)[J]. Urologe A,2004,43 Suppl 3:S146-147.
|
| [31] |
Robertson N, Potter C, Harris AL. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion [J].Cancer Res,2004,64(17):6160-6165.
|
| [32] |
Shareef MM, Udayakumar TS, Sinha VK, et al. Interaction of HIF-1α and Notch3 is required for the expression of carbonic anhydrase 9 in breast carcinoma cells [J]. Genes Cancer,2013,4(11-12):513-523.
|
| [33] |
Soyupak B, Erdogan S. MN/CA IX/CA9 and renal cancer prognosis:Turkey,20090191557 [P/OL]. (2009-07-30)[2014-04-26]. http:/ /www.faqs.org/patents/app/20090191557.
|